| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/26/2002 | EP1083945B1 Encapsulation devices with strand, yarn or mesh core |
| 06/26/2002 | EP0971679B1 Method for the propagation of hair |
| 06/26/2002 | EP0942963A4 Improved nucleic acids for reducing carbohydrate epitopes |
| 06/26/2002 | EP0912895A4 Method for monitoring t-cell reactivity |
| 06/26/2002 | CN1355886A Method for identifying pre-neoplastic and/or neoplastic state in mammals |
| 06/26/2002 | CN1355882A Method for quantifying transforming growth factor-beta 1 and method for detecting cancer by using same |
| 06/26/2002 | CN1355850A Hyaluronidase from hirudinaria manillensis, isolation, purification and recombinant method of production |
| 06/26/2002 | CN1355848A Gene encoding flavone synthase |
| 06/26/2002 | CN1355845A PrP-like gene |
| 06/26/2002 | CN1355844A Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 06/26/2002 | CN1355840A Genetically modified plant cells and plants with increased activity of amylosucrease protein and branching enzyme |
| 06/26/2002 | CN1355813A Peptide having preptin functionality |
| 06/26/2002 | CN1355714A LIM Mineralization protein splice variants |
| 06/26/2002 | CN1355712A Use of antibodies against CD2O for treatment of graft versus host disease |
| 06/26/2002 | CN1355704A Method for preparing membrane visicles |
| 06/26/2002 | CN1355231A Polypeptide-human Alu-RNA bindin 13.75 and polynucleotide for coding it |
| 06/26/2002 | CN1355219A Polypeptide-human Huntingtin interaction protein 16.17 and polynucleotide for coding it |
| 06/25/2002 | US6410828 Nucleotide sequences for use as tools in controlling preferential gene expression in plants |
| 06/25/2002 | US6410723 Nucleotide sequences for use as tools in controlling gene expression |
| 06/25/2002 | US6410721 Polynucleotide decoys that inhibit MHC-II expression and uses thereof |
| 06/25/2002 | US6410720 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 06/25/2002 | US6410717 Nucleotide sequences coding preferential protein for use in generation of disease resistant plants |
| 06/25/2002 | US6410711 Nucleotide sequences coding preferential polypeptide for use in human therapeutics and diagnostics |
| 06/25/2002 | US6410709 Polypeptide; for use in diagnosis and treatment of inflammatory and cell proliferative disorders |
| 06/25/2002 | US6410701 Human neuropeptide receptor |
| 06/25/2002 | US6410691 Monoclonal antibody for use in diagnosis and treatment of immunlogical defects, cancer and rheumatic diseases |
| 06/25/2002 | US6410686 Galanin receptor 2 protein |
| 06/25/2002 | US6410509 Antigen; induce immunology response |
| 06/25/2002 | US6410507 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 06/25/2002 | US6410326 Destroying human tumor cells; obtain tumor cells, transform with replication defective vector, incubate with prodrug, monitor destruction of cells |
| 06/25/2002 | US6410322 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 06/25/2002 | US6410321 Method and formulation for lyophilizing cultured human cells to preserve RNA and DNA contained in cells for use in molecular biology experiments |
| 06/25/2002 | US6410320 Kidney stem cells; for use in treatment of kidney defects |
| 06/25/2002 | US6410319 CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies |
| 06/25/2002 | US6410318 Antibodies directed against binding-associated epitopes |
| 06/25/2002 | US6410317 Recombinase-based methods for producing expression vectors and compositions for use in practicing the same |
| 06/25/2002 | US6410316 Methods for producing a vector producing cell line utilizing a high multiplicity of transduction |
| 06/25/2002 | US6410314 Episomally replicating vector, its preparation and use |
| 06/25/2002 | US6410299 Attenuated forms of bovine viral diarrhea virus |
| 06/25/2002 | US6410298 Reducing frequency homologous recombination; obtain cells, transform with defective nucleotide sequences, monitor homoogous recombination in cells |
| 06/25/2002 | US6410297 Processes for preparation of Marek's disease virus using continuous avian cell lines |
| 06/25/2002 | US6410289 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 06/25/2002 | US6410288 Methods and compositions for synthesis of long chain poly-unsaturated fatty acids |
| 06/25/2002 | US6410266 Eukaryotic cells for use as tools in genetic engineering |
| 06/25/2002 | US6410261 CIITA-interacting proteins and methods of use therefor |
| 06/25/2002 | US6410257 Methods to assay gene function with viral vectors |
| 06/25/2002 | US6410249 Odorant receptors |
| 06/25/2002 | US6410245 Complexing; fusion proteins; quantitative analysis |
| 06/25/2002 | US6410240 Complexing |
| 06/25/2002 | US6410226 Quantitative analysis; calibration |
| 06/25/2002 | US6410219 Dectionn of pathogen deaction of pathogen by complexing |
| 06/25/2002 | US6410032 Attenuated forms of bovine viral diarrhea virus |
| 06/25/2002 | US6410029 2-methoxyestradiol-induced apoptosis in cancer cells |
| 06/25/2002 | US6410027 Methods for preparation of vaccines against cancer |
| 06/25/2002 | US6410026 Preparing rna from isolated cancer cells, making cdna, introducing into host cells, culturing cells to express cancer-derived cdnas, purifying heat shock protein-peptide complexes obtained, administering to treat cancer |
| 06/25/2002 | US6410022 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 06/25/2002 | US6410015 Selecting from bone marrow-derived cells population responsive to transforming growth factor beta-1, using as vehicles for transferring genes encoding therapeutic protein to mammal |
| 06/25/2002 | US6410014 Administering protein-tyrosine kinase chimeras capable of directing cytotoxic t lymphocytes to specifically recognize and lyse target cells |
| 06/25/2002 | US6410013 Viral vectors for use in monitoring HIV drug resistance |
| 06/25/2002 | US6410010 Recombinant P53 adenovirus compositions |
| 06/25/2002 | CA2282042C Solid phase enzyme kinetics screening in microcolonies |
| 06/25/2002 | CA2245462C Methods of modulating cell proliferation through telomerase modulation |
| 06/25/2002 | CA2201587C Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 06/25/2002 | CA2194393C Mammalian telomerase |
| 06/25/2002 | CA2135648C Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 06/25/2002 | CA2095300C Use of genetically modified cells to treat defects, disease or damage of the central nervous system |
| 06/25/2002 | CA2081659C Recombinant human factor viii derivatives |
| 06/25/2002 | CA2051993C Method of culturing mammalian respiratory epithelial cells |
| 06/25/2002 | CA2036814C Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof |
| 06/25/2002 | CA2015583C Large-scale fermenter inoculation with frozen cells |
| 06/23/2002 | WO2002040654A2 A human serpin secreted from lymphoid cells lsi-01 |
| 06/23/2002 | CA2429179A1 Polynucleotide encoding a novel human serpin secreted from lymphoid cells lsi-01 |
| 06/22/2002 | CA2365791A1 Novel bioluminescent assays and bacterial strains useful therein |
| 06/20/2002 | WO2002048385A2 Compositions and methods for the release of nucleic acid molecules from solid matrices |
| 06/20/2002 | WO2002048375A2 Purified active hcv ns2/3 protease |
| 06/20/2002 | WO2002048370A2 Compositions and methods relating to colon specific genes and proteins |
| 06/20/2002 | WO2002048368A2 Proteins associated with cell growth, differentiation, and death |
| 06/20/2002 | WO2002048366A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/20/2002 | WO2002048365A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/20/2002 | WO2002048363A2 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 06/20/2002 | WO2002048348A1 Novel gene existing in human leukocyte antigen domain |
| 06/20/2002 | WO2002048337A2 Secreted human proteins |
| 06/20/2002 | WO2002048333A2 Novel human kinases and uses thereof |
| 06/20/2002 | WO2002048322A2 Recombinant porcine liver esterases, their use and a method for the production thereof |
| 06/20/2002 | WO2002048321A2 Use of acetyl-coa carboxylase for identifying compounds that have an insecticidal effect |
| 06/20/2002 | WO2002048319A1 Telomerase immortalized human liver cell lines |
| 06/20/2002 | WO2002048318A1 Co-culture of hepatocytes and stellate cells |
| 06/20/2002 | WO2002048317A2 Method and device for producing biological tissue in a growth chamber |
| 06/20/2002 | WO2002048316A1 Method for in vitro culture of ovarian follicles |
| 06/20/2002 | WO2002048247A1 Biocompatible, porous material, method for its production and use of the same |
| 06/20/2002 | WO2002048182A2 Interferon-alpha induced gene |
| 06/20/2002 | WO2002048175A2 Mhc class i associated peptides for prevention and treatment of tuberculosis |
| 06/20/2002 | WO2002048167A1 Method for generating immortal dendritic cell lines |
| 06/20/2002 | WO2002047721A1 Silensed anti-cd28 antibodies and use thereof |
| 06/20/2002 | WO2002047534A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 06/20/2002 | WO2002047475A1 Method of efficiently constructing transgenic birds and transgenic birds thus obtained |
| 06/20/2002 | WO2002042475A8 Gene hd3a inducing flowering of plant and utilization thereof |
| 06/20/2002 | WO2002036735A3 Dry powder cells and cell culture reagents and methods of production thereof |
| 06/20/2002 | WO2002020730A3 Manganese lipoxygenase |
| 06/20/2002 | WO2002008751A8 Mild enrichment of foetal cells from peripheral blood and use thereof |